Human kinase profiling platform  


We established a kinase profiling platform with 520 human kinase domains. This platform allows examining inhibitor potency and specificity in cellular lysates, providing an advantage over readily-available biochemical solutions.
1. We offer a complete scan of the kinome (520 KD values), provided the compound to test can be labeled with a fluorophore. Kinetics are also feasible. Please contact us to discuss your needs.

2. Alternatively, we offer readily-available assays for 288 kinase domains, enabling KI determination of label-free test compounds. Kinetics are also feasible. Please contact us to discuss your needs.


We recently published with our customer Merck KGaA the use of FCCS to support the identification of Methionine Aminopeptidase-2 (MetAP-2) inhibitor M8891.
https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01070


See our new publication on the quantifiaction of target occupancy in tissue:
https://doi.org/10.18632/oncotarget.22801


Check out our new GPCR-ligand interaction assay!